Atricure, Inc. income statement

In fiscal 2025, Atricure, Inc. reported revenue of $535m, up 14.9% on the year before, operating income of −$9.4m (a -1.8% margin) and net income of −$11.4m, or −$0.24 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Atricure, Inc.: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	55	59	64	70	82	107	130	155	175	202	231	207	274	330	399	465	535	570
Cost of revenue	13	14	17	20	22	32	37	44	49	55	60	57	68	84	99	118	134	135
Gross profit	42	45	47	50	60	76	93	111	126	147	170	149	206	246	300	348	401	435
Research and development	11	12	12	12	13	19	26	36	34	35	41	43	49	57	74	96	99	98
Selling, general and administrative	35	37	40	45	57	74	94	106	117	130	167	151	205	231	253	291	311	324
Operating income	−16	−3	−5	−7	−11	−16	−27	−31	−25	−17	−33	−44	55	−43	−27	−40	−9	13
Interest expense	1	1	1	1	1	0	0	2	2	5	4	5	5	5	7	6	6	6
Net interest income	—	—	—	—	—	—	—	—	—	3	—	—	—	—	—	—	—	—
Income before tax	−17	−4	−5	−7	−11	−16	−27	−33	−27	−21	−35	−48	50	−46	−30	−44	−10	12
Income tax	−0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	2
Net income	−16	−4	−5	−8	−11	−16	−27	−33	−27	−21	−35	−48	50	−46	−30	−45	−11	11
Diluted EPS	−$1.13	−$0.25	−$0.35	−$0.47	−$0.56	−$0.61	−$0.97	−$1.05	−$0.83	−$0.62	−$0.94	−$1.14	$1.09	−$1.02	−$0.66	−$0.95	−$0.24	$0.22
Diluted shares (average)	—	15m	16m	16m	20m	26m	28m	32m	32m	34m	38m	42m	46m	46m	46m	47m	48m	48m
EBITDA	−13	−1	−3	−5	−9	−13	−22	−23	−17	−10	−26	−36	63	−35	−17	−29	3	25

US$ millions unless shown otherwise. Fiscal quarters.

Atricure, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	116	124	124	136	134	141	141	154
Cost of revenue	29	32	31	35	33	35	32	35
Gross profit	87	93	93	101	101	105	109	119
Research and development	21	35	23	29	23	25	24	26
Selling, general and administrative	73	72	76	78	78	78	85	83
Operating income	−7	−15	−6	−6	0	2	1	10
Interest expense	2	1	1	1	1	2	1	1
Income before tax	−8	−15	−7	−6	−0	2	0	9
Income tax	0	0	0	0	0	1	0	0
Net income	−8	−16	−7	−6	−0	2	0	9
Diluted EPS	−$0.17	−$0.33	−$0.14	−$0.13	−$0.01	$0.04	$0.00	$0.18
EBITDA	−4	−12	−3	−3	3	5	3	13

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ATRC vs BVS ATRC vs TMDX AORT vs ATRC

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Atricure, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Atricure, Inc.